Question : Multiple sclerosis (MS) is a potentially disabling disease of the –
(a) brain and spinal cord (central nervous system)
(b) intestines
(c) heart, arteries and veins
(d) kidneys
Answer (a)
Related facts
- Dr Reddy’s Laboratories on Saturday(26 September 2020) said it has launched Dimethyl Fumarate delayed-release capsules, used to treat multiple sclerosis (MS), in the US market.
- The company’s product is a therapeutic equivalent generic version of Biogen’s Tecfidera delayed-release capsules, the Hyderabad-based drug firm said in a statement.
- According to IQVIA Health data, the Tecfidera brand and generic market had sales of around USD 3.8 billion (about Rs 28,000 crore) in the US for the most recent twelve months ending in June 2020.
- Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).
In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between our brain and the rest of our body.
By — Pankaj Pandey.
READ PLEASE
I was diagnosed with multiple sclerosis 1 month after I turned 50. My grandma is 96 and had it since she was in her 20s. I have been on WORLDHERBSCLINIC MS HERBAL FORMULA , the first TWO MONTHS was daily and now I am on 3 times a week. It has made a tremendous difference for me. The fatigue never gets to me again. When I do too much, I don’t feel weak anymore.